Throughout the last three months, 16 analysts have evaluated Ecolab ECL, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 7 | 8 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 3 | 7 | 0 | 0 |
| 2M Ago | 1 | 1 | 1 | 0 | 0 |
| 3M Ago | 0 | 3 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $228.12, a high estimate of $260.00, and a low estimate of $213.00. This current average reflects an increase of 9.15% from the previous average price target of $209.00.
Interpreting Analyst Ratings: A Closer Look
The analysis of recent analyst actions sheds light on the perception of Ecolab by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Manav Patnaik | Barclays | Raises | Overweight | $260.00 | $225.00 |
| Seth Weber | Wells Fargo | Raises | Overweight | $250.00 | $240.00 |
| Andrew Wittmann | Baird | Raises | Neutral | $232.00 | $184.00 |
| John McNulty | BMO Capital | Raises | Market Perform | $227.00 | $212.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $237.00 | $220.00 |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $238.00 | - |
| John Roberts | Mizuho | Raises | Neutral | $216.00 | $210.00 |
| Manav Patnaik | Barclays | Raises | Equal-Weight | $225.00 | $215.00 |
| Shlomo Rosenbaum | Stifel | Raises | Hold | $225.00 | $193.00 |
| Jeffrey Zekaukas | JP Morgan | Raises | Neutral | $220.00 | $200.00 |
| Ashish Sabadra | RBC Capital | Raises | Outperform | $238.00 | $213.00 |
| Steve Byrne | B of A Securities | Raises | Neutral | $216.00 | $185.00 |
| Joshua Spector | UBS | Raises | Buy | $227.00 | $211.00 |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $213.00 | - |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $213.00 | - |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $213.00 | - |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Ecolab. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ecolab compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Capture valuable insights into Ecolab's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Ecolab analyst ratings.
All You Need to Know About Ecolab
Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management solutions across its end markets. The company has a strong hold on the U.S. market and is growing its presence abroad.
Ecolab: A Financial Overview
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Positive Revenue Trend: Examining Ecolab's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.28% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Ecolab's net margin excels beyond industry benchmarks, reaching 10.29%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Ecolab's ROE excels beyond industry benchmarks, reaching 5.12%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Ecolab's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.85% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Ecolab's debt-to-equity ratio surpasses industry norms, standing at 1.09. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
What Are Analyst Ratings?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
